{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:59:48Z","timestamp":1795042788174,"version":"4.10.2"},"reference-count":40,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Atypical hemolytic uremic syndrome (aHUS) is a rare renal thrombotic microangiopathy commonly associated with rare genetic variants in complement system genes, unique to each patient\/family. Here, we report 14 sporadic aHUS patients carrying the same mutation, R139W, in the complement C3 gene. The clinical presentation was with a rapid progression to end-stage renal disease (6 of 14) and an unusually high frequency of cardiac (8 of 14) and\/or neurologic (5 of 14) events. Although resting glomerular endothelial cells (GEnCs) remained unaffected by R139W-C3 sera, the incubation of those sera with GEnC preactivated with pro-inflammatory stimuli led to increased C3 deposition, C5a release, and procoagulant tissue-factor expression. This functional consequence of R139W-C3 resulted from the formation of a hyperactive C3 convertase. Mutant C3 showed an increased affinity for factor B and a reduced binding to membrane cofactor protein (MCP; CD46), but a normal regulation by factor H (FH). In addition, the frequency of at-risk FH and MCP haplotypes was significantly higher in the R139W-aHUS patients, compared with normal donors or to healthy carriers. These genetic background differences could explain the R139W-aHUS incomplete penetrance. These results demonstrate that this C3 mutation, especially when associated with an at-risk FH and\/or MCP haplotypes, becomes pathogenic following an inflammatory endothelium-damaging event.<\/jats:p>","DOI":"10.1182\/blood-2011-10-383281","type":"journal-article","created":{"date-parts":[[2012,1,14]],"date-time":"2012-01-14T07:28:32Z","timestamp":1326526112000},"page":"4182-4191","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":137,"title":["A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function"],"prefix":"10.1182","volume":"119","author":[{"given":"Lubka T.","family":"Roumenina","sequence":"first","affiliation":[{"name":"Cordeliers Research Center, Inserm Unit\u00e9 Mixte de Recherche en Sant\u00e9 (UMRS) 872, Paris, France;"},{"name":"Universit\u00e9 Pierre et Marie Curie, Paris, France;"},{"name":"Universit\u00e9 Paris Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Frimat","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes, Paris, France;"},{"name":"Inserm U845, H\u00f4pital Necker, Paris, France;"},{"name":"Service de N\u00e9phrologie, H\u00f4pital Claude Huriez, Centre Hospitalier Universitaire, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Washington University School of Medicine, St Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Provot","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie, H\u00f4pital Claude Huriez, Centre Hospitalier Universitaire, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Agnes","family":"Dragon-Durey","sequence":"additional","affiliation":[{"name":"Cordeliers Research Center, Inserm Unit\u00e9 Mixte de Recherche en Sant\u00e9 (UMRS) 872, Paris, France;"},{"name":"Universit\u00e9 Paris Descartes, Paris, France;"},{"name":"Hopital Europeen Georges Pompidou, Service d'Immunologie Biologique, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Bordereau","sequence":"additional","affiliation":[{"name":"Cordeliers Research Center, Inserm Unit\u00e9 Mixte de Recherche en Sant\u00e9 (UMRS) 872, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Bigot","sequence":"additional","affiliation":[{"name":"Inserm U845, H\u00f4pital Necker, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Hue","sequence":"additional","affiliation":[{"name":"Cordeliers Research Center, Inserm Unit\u00e9 Mixte de Recherche en Sant\u00e9 (UMRS) 872, Paris, France;"},{"name":"Universit\u00e9 Pierre et Marie Curie, Paris, France;"},{"name":"Universit\u00e9 Paris Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Satchell","sequence":"additional","affiliation":[{"name":"Academic Renal Unit, University of Bristol, Southmead Hospital, Bristol, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Mathieson","sequence":"additional","affiliation":[{"name":"Academic Renal Unit, University of Bristol, Southmead Hospital, Bristol, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Mousson","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie, Centre Hospitalier Universitaire, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Noel","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie, H\u00f4pital Claude Huriez, Centre Hospitalier Universitaire, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Sautes-Fridman","sequence":"additional","affiliation":[{"name":"Cordeliers Research Center, Inserm Unit\u00e9 Mixte de Recherche en Sant\u00e9 (UMRS) 872, Paris, France;"},{"name":"Universit\u00e9 Pierre et Marie Curie, Paris, France;"},{"name":"Universit\u00e9 Paris Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Halbwachs-Mecarelli","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes, Paris, France;"},{"name":"Inserm U845, H\u00f4pital Necker, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Washington University School of Medicine, St Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Lionet","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie, H\u00f4pital Claude Huriez, Centre Hospitalier Universitaire, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Fremeaux-Bacchi","sequence":"additional","affiliation":[{"name":"Cordeliers Research Center, Inserm Unit\u00e9 Mixte de Recherche en Sant\u00e9 (UMRS) 872, Paris, France;"},{"name":"Hopital Europeen Georges Pompidou, Service d'Immunologie Biologique, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"17","key":"2019111808325842800_B1","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome.","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111808325842800_B2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0030-1262886","article-title":"Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes.","volume":"36","author":"Le Quintrec","year":"2010","journal-title":"Semin Thromb Hemost"},{"issue":"1-2","key":"2019111808325842800_B3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","article-title":"Alternative complement pathway assessment in patients with atypical HUS.","volume":"365","author":"Roumenina","year":"2011","journal-title":"J Immunol Methods"},{"issue":"9","key":"2019111808325842800_B4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis.","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"issue":"13","key":"2019111808325842800_B5","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.","volume":"112","author":"Fremeaux-Bacchi","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111808325842800_B6","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2215\/CJN.06281208","article-title":"A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure.","volume":"4","author":"Lhotta","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2019111808325842800_B7","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.","volume":"31","author":"Maga","year":"2010","journal-title":"Hum Mutat"},{"issue":"10","key":"2019111808325842800_B8","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2019111808325842800_B9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2019111808325842800_B10","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2009-01-197640","article-title":"Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome.","volume":"114","author":"Roumenina","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2019111808325842800_B11","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI43343","article-title":"Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation.","volume":"120","author":"Martinez-Barricarte","year":"2010","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111808325842800_B12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"7058","key":"2019111808325842800_B13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature04005","article-title":"Structures of complement component C3 provide insights into the function and evolution of immunity.","volume":"437","author":"Janssen","year":"2005","journal-title":"Nature"},{"issue":"7116","key":"2019111808325842800_B14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature05172","article-title":"Structure of C3b reveals conformational changes that underlie complement activity.","volume":"444","author":"Janssen","year":"2006","journal-title":"Nature"},{"issue":"7","key":"2019111808325842800_B15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ni.1755","article-title":"Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.","volume":"10","author":"Wu","year":"2009","journal-title":"Nat Immunol"},{"issue":"7","key":"2019111808325842800_B16","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ni.1756","article-title":"Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.","volume":"10","author":"Rooijakkers","year":"2009","journal-title":"Nat Immunol"},{"issue":"6012","key":"2019111808325842800_B17","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.1195821","article-title":"Structures of C3b in complex with factors B and D give insight into complement convertase formation.","volume":"330","author":"Forneris","year":"2010","journal-title":"Science"},{"issue":"9","key":"2019111808325842800_B18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001122","article-title":"Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens.","volume":"6","author":"Persson","year":"2011","journal-title":"PLoS Pathog"},{"issue":"13","key":"2019111808325842800_B19","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis.","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"issue":"9","key":"2019111808325842800_B20","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.ki.5000277","article-title":"Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF.","volume":"69","author":"Satchell","year":"2006","journal-title":"Kidney Int"},{"issue":"12","key":"2019111808325842800_B21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/BF01120205","article-title":"Monoclonal antibodies against the complement control protein factor H (beta 1 H).","volume":"3","author":"Sim","year":"1983","journal-title":"Biosci Rep"},{"issue":"2","key":"2019111808325842800_B22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2249.1991.tb05624.x","article-title":"Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassay.","volume":"83","author":"Cho","year":"1991","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"2019111808325842800_B23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2019111808325842800_B24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1681\/ASN.2007080923","article-title":"The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome.","volume":"19","author":"Martinez-Barricarte","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"1-2","key":"2019111808325842800_B25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0161-5890(00)00036-5","article-title":"Complement-endothelial cell interactions: pathophysiological implications.","volume":"37","author":"Tedesco","year":"2000","journal-title":"Mol Immunol"},{"issue":"9","key":"2019111808325842800_B26","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1084\/jem.185.9.1619","article-title":"The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity.","volume":"185","author":"Tedesco","year":"1997","journal-title":"J Exp Med"},{"issue":"16","key":"2019111808325842800_B27","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/emboj.2009.184","article-title":"Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.","volume":"28","author":"Janssen","year":"2009","journal-title":"EMBO J"},{"issue":"11","key":"2019111808325842800_B28","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.4049\/jimmunol.0902310","article-title":"Coexistence of closed and open conformations of complement factor B in the alternative pathway C3bB(Mg2+) proconvertase.","volume":"183","author":"Torreira","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"2019111808325842800_B29","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1073\/pnas.0810860106","article-title":"3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.","volume":"106","author":"Torreira","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111808325842800_B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03552.x","article-title":"Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.","volume":"151","author":"de Cordoba","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2019111808325842800_B31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1532\/IJH97.E0713","article-title":"Dilated cardiomyopathy during the course of hemolytic uremic syndrome.","volume":"86","author":"Alexopoulou","year":"2007","journal-title":"Int J Hematol"},{"issue":"5","key":"2019111808325842800_B32","first-page":"237","article-title":"[Dilated cardiomyopathy during post-partum hemolytic and uremic syndrome (HUS)].","volume":"12","author":"Leray","year":"1991","journal-title":"Nephrologie"},{"issue":"9","key":"2019111808325842800_B33","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/ndt\/13.9.2419","article-title":"Recurrent ventricular tachycardia complicating atypical haemolytic-uraemic syndrome.","volume":"13","author":"Prakash","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2019111808325842800_B34","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/ndt\/gfq160","article-title":"Myocardial infarction is a complication of factor H-associated atypical HUS.","volume":"25","author":"Sallee","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2019111808325842800_B35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00858990","article-title":"Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome.","volume":"9","author":"Gallo","year":"1995","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"2019111808325842800_B36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/adc.76.6.518","article-title":"Heterogeneity of atypical haemolytic uraemic syndromes.","volume":"76","author":"Neuhaus","year":"1997","journal-title":"Arch Dis Child"},{"issue":"19","key":"2019111808325842800_B37","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2009-05-223834","article-title":"Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.","volume":"114","author":"Abarrategui-Garrido","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2019111808325842800_B38","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome.","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2019111808325842800_B39","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2215\/CJN.01090209","article-title":"Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.","volume":"4","author":"Mache","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2019111808325842800_B40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1055\/s-0030-1262889","article-title":"New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.","volume":"36","author":"Kose","year":"2010","journal-title":"Semin Thromb Hemost"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/18\/4182\/1353070\/zh801812004182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/18\/4182\/1353070\/zh801812004182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:56:50Z","timestamp":1574085410000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/18\/4182\/30101\/A-prevalent-C3-mutation-in-aHUS-patients-causes-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,3]]},"references-count":40,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012,5,3]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-10-383281","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,3]]}}}